The Central government hasn’t included antiviral drug Molnupiravir in its revised clinical guidance for management of adult COVID-19 patients, and specified that Remdesivir and Tocilizumab should be prescribed under certain conditions only. The guidelines were revised by the All India Institute of Medical Science and Indian Council of Medical Research -COVID-19 National Task Force/ Joint Monitoring Group, under the Health …